USD 2.5 Billion
Report ID: SQMIG35A2458 | Region: Global | Published Date: July, 2030 | Pages: 219 | Tables: 90 | Figures: 76
Global Oncology Information Systems Market size was valued at USD 2.5 Billion in 2022 and is poised to grow from USD 2.7 Billion in 2023 to USD 4.96 Billion in 2031, at a CAGR of 7.9 % during the forecast period (2024-2031).
The rising global prevalence of cancer, coupled with the rising development expenditure on cancer treatments and solutions, and rising adoption of OIS remedies by healthcare facilities are some of the key factors expected to drive market growth. According to percancer.org, over 1.9 million additional instances of cancer are expected to be detected in the United States alone by 2021. A wide range of new technologies are being developed, with the potential to completely change the treatment routine.
The growing demand for OIS software to help streamline the process of patient data and information administration has boosted the need for various types of OIS software. Companies' increased spending in cancer research are expected to boost market expansion. The market is predicted to increase significantly in the coming years, and companies are actively investing in the creation of innovative and highly technological goods. Major firms' investments in OIS development will be a tremendous potential because of a massive influx of funds and resources for the healthcare industry, particularly in the field detecting cancer. The government of the United Kingdom intends to spend $26 billion on development and research by 2024-2025.
The Office for Life Sciences has been awarded USD 123.5 million towards the government's Life Sciences Vision & cancer research. Such activities, in conjunction with new product & software launches by various companies, are likely to fuel market expansion. The development of digital currencies & Artificial Intelligence has reduced the use of paper-based therapies, medical records, and so on, and has made patient data management simple for both carers and patients. Furthermore, AI in oncology represents a few of the variables driving market growth. Because systems and software are largely employed by pharmaceutical businesses and hospitals, they have significant demand in end-use facilities.
Furthermore, market management is launching new products in the same group, but without insufficient innovation. As a result, corporations may benefit from investing in R&D to create products with greater features. For example, Varian Healthcare Systems, Inc. announced a USD 10.0 million investment in a strategic collaboration deal with COTA, Inc., an archive of clinical information in the oncology industry. Both organizations want to help cancer clinics by providing decision support tools, analysis of data, operational choices, and other services. It aids in the efficient management of treatment schedules, therapy delivery, and planning, as well as the promotion of information flow between Radiation Therapy (RT) departments with healthcare businesses.
OIS also ensures that clinicians offer treatment plans with the correct procedures to the correct patient, with the correct cancer site, thereby ensuring an effective treatment by offering full details about RT and treatment results to doctors when needed for the purpose of assessing and to improve treatment quality. Furthermore, the demand for medical planning systems will increase in the future due to benefits such as storing vast amounts of info and accessing information as and when needed, as well as assisting doctors in scheduling medical care of varied patients. A few of the market's major companies include Varian Healthcare Systems, Elekta AB, & Accuray Inc.
Global Market Size
USD 2.5 Billion
Largest Segment
Solutions
Fastest Growth
Solutions
Growth Rate
7.9% CAGR
To get more reports on the above market click here to Buy The Report
The global oncology information systems market is segmented based on product, application, end user, and region. Based on product, the market is bifurcated into Solutions, and Professional Services. Based on application, the market is segmented into Medical Oncology, Radiation Oncology, and Surgical Oncology. Based on end user, the market is segmented into Hospitals & Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions, and Research Facilities. Based on region, the global oncology information systems market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Oncology Information Systems Market Analysis by Product
The global market has been divided into solutions & professional services based on products and services. By 2022, the solution segment would have accounted for 73.6% of worldwide sales. During the time frame in question, this industry is also expected to increase at the fastest pace of 8.2%. This segment is leading the market due to increased usage by medical professionals for proper radiological imaging management. These technologies aid in the collection of cancer patient feedback and promote direct communication between patients and clinicians, resulting in the expansion of this market sector.
The development of advanced OIS Options, that helps in enhanced handling of patient information and enhances cancer therapy, can also be related to the segment's rise. The solutions section is further subdivided into patient data systems and medical planning systems, with the latter accounting for the biggest market share in 2021. Professional services, on the other hand, are becoming more widely recognized, as most medical facilities outsource OIS services owing to a shortage of competent professionals in medical facilities. These services include online consultation as well as customized schedules and reports, which help to improve the quality of care.
Oncology Information Systems Market Analysis by Application
In 2022, the medical oncologist segment was responsible for 61.5% of global sales. Due to rapid breakthroughs in immunotherapy, hormonal therapy, and specific treatment for effectively treating various malignancies, the healthcare oncology segment is predicted to grow at the fastest CAGR of 8.2% during the forecast period. Furthermore, various activities relevant to studies on cancer are being conducted by prominent organizations, which is favorably driving market growth.
The surgical oncology segment is also expected to grow significantly over the next few years. The main form of therapy for most solid cancers is no longer surgery; instead, a mix of surgery and multi-modal therapies focusing on radiotherapy, targeted genetic medications, and chemotherapy is preferred. Cytoreductive operations, solitary limb circulation, endoscopic cancer surgery, & tumor surgery are all procedures that can be performed at highly specialized hospitals. As a result, the increasing complexity of surgical therapy for solid tumors is expected to drive market growth.
To get detailed analysis on other segments, Request For Sample Report
In 2022, the North America regional market had the highest revenue share of 38.3%. The presence of advanced healthcare infrastructure and increased awareness about patient data management in the region are key elements driving this expansion. Furthermore, the increasing use of OIS to track and record cancer patients' treatment outcomes, as well as the growing use of EMR in making better treatment decisions, are likely to drive regional market expansion. The increasing demand for treatment schedule management, dosage control, and therapy planning is likely to drive demand for OIS in this part of the world.
Asia Pacific is expected to expand at the fastest rate of 8.9%. Asian countries, on the other hand, are experiencing significant demand for OIS & are gradually developing as a result of government support and increased understanding about the advantages of these systems. This location may act as a hot income pocket for players looking to capitalize on the region's potential. As a result, firms seeking a big portion of this market must establish specific pricing policies as well as marketing tactics tailored to this region in order to gain a footing in these markets.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Oncology Information Systems Market Drivers
Technological Advancements
Oncology Information Systems Market Restraints
High Implementation and Maintenance Costs
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
Key companies concentrate mainly on incorporating advances in technology through the launch of web-based cancer treatment solutions and AI-based OIS solutions with the goal of improving the treatment regime, which is Expected to have a positive effect on market growth in the future years.
Oncology Information Systems Market Top Player’s Company Profiles
Oncology Information Systems Market Recent Developments
In June 2023, RaySearch Laboratories AB announced a strategic collaboration agreement with B dot Medical Inc. aimed at advancing the field of proton therapy by development and validation of intregrations between RaySearch’s treatment planning system RayStation, oncology information system RayCare and B dot Medical’s ultra-compact proton therapy system.
In May 2023, RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation oncology information system.
In September 2022, Evernorth, the health services arm of Cigna, and Varian, part of Siemens Healthineers, partnered to improve data standardization and interoperability in oncology using Health Level Seven International's Fast Healthcare Interoperability Resources, or FHIR.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global oncology information systems market analysis, the rising global prevalence of cancer, rising development expenditure on cancer treatments and solutions, and rising adoption of OIS remedies by healthcare facilities are some of the key factors expected to drive market growth. According to percancer.org, over 1.9 million additional instances of cancer are expected to be detected in the United States alone by 2021. A wide range of new technologies are being developed, with the potential to completely change the treatment routine. Oncology information systems are increasingly incorporating features that promote patient engagement and personalized care. Patient portals, remote monitoring, and communication tools enable patients to actively participate in their treatment journey, access their health records, and communicate with healthcare providers. These systems also support personalized treatment planning based on patient-specific characteristics and genetic information.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 2.5 Billion |
Growth Rate | 7.9% |
Base year | 2022 |
Forecast period | 2024-2031 |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global Oncology Information Systems Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Oncology Information Systems Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Oncology Information Systems Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Oncology Information Systems Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
SPEAK TO AN ANALYSTGet lifetime access to our reports
Basic Plan $5,000 Team Plan $10,000 SUBSCRIBE NOWWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35A2458